Researchers conducted an observational study of 600 patients who used FDgard to manage their functional dyspepsia.
Ann Arbor-based Michigan Medicine Gastroenterology Clinic Director William Chey, MD, presented the results at ACG 2017.
Here’s what you should know:
1. Approximately 95 percent of patients experienced either major or moderate improvements of their functional dyspepsia.
2. Concerning epigastric pain syndrome, 92.5 percent of patients experienced improved upper abdominal pain.
3. Around 86.5 percent of postprandial distress syndrome patients achieved symptom relief within two hours of taking FDgard.
ACG 2017 took place in Orlando, Fla., Oct. 13 to Oct. 18.
More articles on gastroenterology:
GI center to know: Affiliated Endoscopy Services of Clifton
Atlantic Digestive Specialists, Gastro Health & more — 3 GI practices in the news
Motus GI’s Pure-Vu system effective in adequately prepping colons — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
